APA (7th ed.) Citation

Chen, C. D., Franklin, E. E., Li, Y., Joseph‐Mathurin, N., Burns, A., Hobbs, D. A., . . . Perrin, R. J. (2024). Anti‐amyloid‐β treatment effects on dominantly inherited Alzheimer disease neuropathology: Comparing autopsy findings with biomarker outcomes from the DIAN‐TU‐001 trial of gantenerumab or solanezumab. Alzheimer's & dementia: the journal of the Alzheimer's Association, 20(S8), 1. https://doi.org/10.1002/alz.095436

Chicago Style (17th ed.) Citation

Chen, Charles D., et al. "Anti‐amyloid‐β Treatment Effects on Dominantly Inherited Alzheimer Disease Neuropathology: Comparing Autopsy Findings with Biomarker Outcomes from the DIAN‐TU‐001 Trial of Gantenerumab or Solanezumab." Alzheimer's & Dementia: The Journal of the Alzheimer's Association 20, no. S8 (2024): 1. https://doi.org/10.1002/alz.095436.

MLA (9th ed.) Citation

Chen, Charles D., et al. "Anti‐amyloid‐β Treatment Effects on Dominantly Inherited Alzheimer Disease Neuropathology: Comparing Autopsy Findings with Biomarker Outcomes from the DIAN‐TU‐001 Trial of Gantenerumab or Solanezumab." Alzheimer's & Dementia: The Journal of the Alzheimer's Association, vol. 20, no. S8, 2024, p. 1, https://doi.org/10.1002/alz.095436.